Aurobindo pharma: Game-Changing Deal Massive Profits Expected,Target ā,¹1200 by Year End| Anil Singhvi
Big news for Aurobindo Pharma
Approval for the launch of Aurobindo Pharma's drug Revlimid
Revlimid's market size is ā¹35 thousand crores
Aurobindo Pharma estimates sales of ā¹4000-5000 crore
Why did Anil Singhvi say - 'Share price ready to reach ā¹ 1200 within a year'
Written By: Zee Business Video Team